BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16000320)

  • 1. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
    Lesueur F; Pharoah PD; Laing S; Ahmed S; Jordan C; Smith PL; Luben R; Wareham NJ; Easton DF; Dunning AM; Ponder BA
    Hum Mol Genet; 2005 Aug; 14(16):2349-56. PubMed ID: 16000320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.
    Ruivenkamp CA; van Wezel T; Zanon C; Stassen AP; Vlcek C; Csikós T; Klous AM; Tripodis N; Perrakis A; Boerrigter L; Groot PC; Lindeman J; Mooi WJ; Meijjer GA; Scholten G; Dauwerse H; Paces V; van Zandwijk N; van Ommen GJ; Demant P
    Nat Genet; 2002 Jul; 31(3):295-300. PubMed ID: 12089527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
    Ruivenkamp C; Hermsen M; Postma C; Klous A; Baak J; Meijer G; Demant P
    Oncogene; 2003 May; 22(22):3472-4. PubMed ID: 12776199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphism analysis in the human phosphatase PTPrj gene using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
    Powell N; Dudley E; Morishita M; Bogdanova T; Tronko M; Thomas G
    Rapid Commun Mass Spectrom; 2004; 18(19):2249-54. PubMed ID: 15384144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
    Vega A; Salas A; Milne RL; Carracedo B; Ribas G; Ruibal A; de León AC; González-Hernández A; Benítez J; Carracedo A
    Gynecol Oncol; 2009 Jan; 112(1):210-4. PubMed ID: 18950845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population.
    Yin J; Vogel U; Ma Y; Qi R; Wang H
    Mutat Res; 2008 May; 641(1-2):12-8. PubMed ID: 18358500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.
    Cebrian A; Pharoah PD; Ahmed S; Smith PL; Luccarini C; Luben R; Redman K; Munday H; Easton DF; Dunning AM; Ponder BA
    Cancer Res; 2006 Jan; 66(2):1225-33. PubMed ID: 16424062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in epigenetic genes and breast cancer risk.
    Cebrian A; Pharoah PD; Ahmed S; Ropero S; Fraga MF; Smith PL; Conroy D; Luben R; Perkins B; Easton DF; Dunning AM; Esteller M; Ponder BA
    Carcinogenesis; 2006 Aug; 27(8):1661-9. PubMed ID: 16501248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
    Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
    Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
    Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.